Lars Fruergaard Jørgensen CEO of Novo Nordisk
In Good Company with Nicolai Tangen
Intro
This chapter explores the global issue of obesity, emphasizing its recognition as a complex disease influenced by various factors like genetics and food accessibility. The speakers discuss the shortcomings of past medical approaches and highlight advancements in treatment stemming from decades of research.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
